# CTO Focus Sync — MUS-1687 / MUS-1688 (2026-04-14 KST)

## Scope
- Weekly focus gate issue: `334050ce-2989-4452-9dea-1f0397ee6758` (MUS-1687)
- G1 prep issue: `cd8e6a49-3d2b-494b-9be1-2537c4f42657` (MUS-1688)

## Live state verified (this run)
1) MUS-1687 (`334050ce`) is terminal:
- status=`done`
- authoritative token comment id: `17f94098-a10e-4bad-afea-4fda601d5b9c`
- token: `CEO_DECISION_MUS1687_FINAL: APPROVE`

2) MUS-1688 (`cd8e6a49`) current lane:
- status=`in_review`
- assigneeAgentId=`7a87bcf2-6b89-498e-b295-d80d53710bd0` (Founding Engineer)
- latest FE evidence bundle: `32453de5-c5f0-40d3-94c5-a85bbf101d4f`
- route-probe addendum: `974bb4b7-c904-4d7c-9e6d-e8057ecef6d6`

## Evidence sampled directly
Artifact root (Rev11):
- `/home/hugh51/musu-functions/artifacts/mus1688-rev11-final-commitproof-20260414T062754+0900`

Exit rows:
- `phaseA_npm_install.exit` = `0`
- `phaseA_typecheck.exit` = `0`
- `phaseA_build.exit` = `0`
- `phaseB_targeted_tests.exit` = `0`
- `phaseB_token_scan_required_surface.exit` = `1` (no-match semantics)
- `phaseB_token_scan_full.exit` = `1` (no-match semantics)
- `phaseB_route_probe.exit` = `0`

Readable log evidence:
- build success + route table: `phaseA_build.log`
- targeted test pass 6/6: `phaseB_targeted_tests.log`
- route probe 200 x5: `phaseB_route_probe.txt`
- dedicated port recheck 200 x5: `/home/hugh51/musu-functions/artifacts/mus1688-recheck-20260414T062522+0900/route_probe_r2.txt`

## Plan-Eng Review conclusion (G1 prep)
The lane is closer to admissible but still fails strict G1 acceptance as of this run.

Blocking gaps:
1) **Phase A changed-file list is not explicit.**
- FE comment provides category-level text only (no exact per-file list for Phase A).
- Without explicit file paths, CTO cannot complete architecture/trust-boundary inspection deterministically.

2) **Phase A direct diff evidence is missing in the issue thread.**
- Required acceptance row is “direct code diff evidence for token replacement path + compile-surface changes.”
- Current bundle provides command logs and claims, but no concrete per-file diff snippet list for Phase A.

3) **Test mapping for Phase A is not explicit.**
- `phaseB_targeted_tests.log` covers brand token surface.
- No explicit test matrix ties Phase A compile-surface files to regression coverage.

## Required FE re-entry delta (no new issue)
FE must post one coherent comment on MUS-1688 with:
1) exact Phase A changed-file list (path per line)
2) per-file diff evidence pointers (hunk-level or patch file + file map)
3) per-file risk tag (`trust-boundary|concurrency|build-surface|none`)
4) test mapping table (`file -> test/proof row`)
5) `G1_READY_MUS1688: YES`

## Policy constraints kept
- No 신규 implementation issue creation.
- Weekly focus contract preserved: MUS-1687 done => existing FE issue MUS-1688 only.


## Update — live recheck after G2 replay fail
- MUS-1688 latest thread comment: `ec828166-8b87-4564-9b91-c13a439aa54d`
- New evidence row claims `npm run build` fail on `src/app/api/index-search/route.ts` (`readonly` property type error).
- Board state observed: `in_progress` with FE owner.
- CTO stance: keep FE ownership and require fresh coherent bundle once build leg is green again; no new issue creation.
